Oak Thistle LLC Purchases 129 Shares of Mettler-Toledo International Inc. (NYSE:MTD)

Oak Thistle LLC grew its holdings in shares of Mettler-Toledo International Inc. (NYSE:MTD) by 21.9% during the fourth quarter, HoldingsChannel reports. The institutional investor owned 719 shares of the medical instruments supplier’s stock after buying an additional 129 shares during the period. Oak Thistle LLC’s holdings in Mettler-Toledo International were worth $880,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also recently modified their holdings of the business. State Street Corp boosted its holdings in Mettler-Toledo International by 1.0% during the 3rd quarter. State Street Corp now owns 954,653 shares of the medical instruments supplier’s stock valued at $1,431,693,000 after acquiring an additional 9,009 shares during the period. Geode Capital Management LLC boosted its stake in shares of Mettler-Toledo International by 0.8% during the third quarter. Geode Capital Management LLC now owns 547,439 shares of the medical instruments supplier’s stock valued at $818,906,000 after purchasing an additional 4,166 shares during the period. Barclays PLC boosted its stake in shares of Mettler-Toledo International by 8.3% during the third quarter. Barclays PLC now owns 256,602 shares of the medical instruments supplier’s stock valued at $384,822,000 after purchasing an additional 19,609 shares during the period. JPMorgan Chase & Co. grew its holdings in shares of Mettler-Toledo International by 14.7% in the third quarter. JPMorgan Chase & Co. now owns 221,799 shares of the medical instruments supplier’s stock worth $332,634,000 after purchasing an additional 28,478 shares during the last quarter. Finally, Loomis Sayles & Co. L P lifted its holdings in Mettler-Toledo International by 1.8% during the 3rd quarter. Loomis Sayles & Co. L P now owns 209,902 shares of the medical instruments supplier’s stock valued at $314,790,000 after buying an additional 3,644 shares in the last quarter. 95.07% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

A number of equities analysts have commented on MTD shares. Wells Fargo & Company dropped their target price on shares of Mettler-Toledo International from $1,400.00 to $1,350.00 and set an “equal weight” rating on the stock in a research note on Monday, November 11th. Evercore ISI raised Mettler-Toledo International from an “in-line” rating to an “outperform” rating and increased their price objective for the stock from $1,375.00 to $1,450.00 in a research note on Thursday, January 2nd. Robert W. Baird lowered their target price on Mettler-Toledo International from $1,375.00 to $1,310.00 and set a “neutral” rating for the company in a report on Monday, November 11th. Wolfe Research assumed coverage on Mettler-Toledo International in a research note on Friday, December 13th. They set a “peer perform” rating on the stock. Finally, Citigroup raised shares of Mettler-Toledo International from a “sell” rating to a “neutral” rating and upped their price objective for the stock from $1,200.00 to $1,300.00 in a research note on Wednesday, December 11th. One research analyst has rated the stock with a sell rating, six have assigned a hold rating and three have issued a buy rating to the company. According to data from MarketBeat, the company currently has a consensus rating of “Hold” and an average price target of $1,351.25.

Insider Transactions at Mettler-Toledo International

In related news, Director Elisha W. Finney sold 76 shares of the company’s stock in a transaction dated Monday, November 11th. The stock was sold at an average price of $1,311.75, for a total transaction of $99,693.00. Following the transaction, the director now directly owns 240 shares of the company’s stock, valued at $314,820. This represents a 24.05 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this link. Also, insider Gerry Keller sold 140 shares of the firm’s stock in a transaction dated Tuesday, December 3rd. The stock was sold at an average price of $1,254.09, for a total value of $175,572.60. Following the completion of the sale, the insider now directly owns 6 shares of the company’s stock, valued at approximately $7,524.54. This represents a 95.89 % decrease in their position. The disclosure for this sale can be found here. Insiders own 1.94% of the company’s stock.

Mettler-Toledo International Price Performance

Shares of MTD stock opened at $1,278.98 on Thursday. The stock’s 50-day moving average is $1,246.46 and its 200 day moving average is $1,345.43. Mettler-Toledo International Inc. has a 1-year low of $1,133.46 and a 1-year high of $1,546.93. The company has a market cap of $26.99 billion, a P/E ratio of 34.48, a PEG ratio of 4.21 and a beta of 1.12.

Mettler-Toledo International (NYSE:MTD) last released its quarterly earnings results on Thursday, November 7th. The medical instruments supplier reported $10.21 earnings per share for the quarter, beating analysts’ consensus estimates of $10.00 by $0.21. The business had revenue of $954.54 million for the quarter, compared to analysts’ expectations of $941.93 million. Mettler-Toledo International had a net margin of 21.15% and a negative return on equity of 531.78%. On average, analysts anticipate that Mettler-Toledo International Inc. will post 40.42 EPS for the current year.

Mettler-Toledo International Company Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.